Avid Bioservices, Inc. Business Finance Contracts & Agreements
35 Contracts & Agreements
- Assignment Agreements (1 contract)
- Credit Agreements (2)
- Indenture Agreements (3)
- Loan Agreements (3)
- Note Agreements (3)
- Purchase Agreements (2)
- Registration Rights Agreements (3)
- Security Agreements (4)
- Share Agreements (2)
- Stock Agreements (6)
- Underwriting Agreements (3)
- Warrant Agreements (3)
- Amendment No. 2 to Credit Agreement, dated as of March 12, 2024, by and among the Company, the lenders party thereto and Bank of America, N.A. as administrative Agent (Filed With SEC on March 14, 2024)
- Indenture, dated as of March 12, 2024, by and between the Company and U.S. Bank Trust Company, National Association, as Trustee (Filed With SEC on March 14, 2024)
- Amendment No. 1 to Credit Agreement, dated as of October 27, 2023, among Avid Bioservices, Inc., as the Borrower, the Lenders party hereto, and Bank of America, N.A., as... (Filed With SEC on November 2, 2023)
- First Supplemental Indenture, dated as of April 30, 2021, by and among Avid SPV, LLC, Avid Bioservices, Inc. and U.S. Bank National Association (Filed With SEC on May 5, 2021)
- Indenture, dated as of March 12, 2021, by and among Avid SPV, LLC, Avid Bioservices, Inc. and U.S. Bank National Association, as trustee relating to the 1.250% Exchangeable Senior... (Filed With SEC on March 12, 2021)
- Underwriting Agreement, dated December 10, 2020, between Avid Bioservices, Inc. and RBC Capital Markets, LLC (Filed With SEC on December 14, 2020)
- Promissory Note, dated April 17, 2020, by and between Avid Bioservices, Inc. and City National Bank (Filed With SEC on April 23, 2020)
- Amendment to Rights Agreement dated September 23, 2019, between Avid Bioservices, Inc. and Broadridge Corporate Issuer Solutions, Inc., as rights agent (Filed With SEC on September 23, 2019)
- Asset Assignment and Purchase Agreement by and between Avid Bioservices, Inc. and Oncologie, Inc., dated February 12, 2018 (Filed With SEC on July 16, 2018)
- Underwriting Agreement, dated February 14, 2018, between Avid Bioservices, Inc. and Wells Fargo Securities, LLC (Filed With SEC on February 16, 2018)
- AMENDED AND RESTATED RIGHTS AGREEMENT by and between PEREGRINE PHARMACEUTICALS, INC. and BROADRIDGE CORPORATE ISSUER SOLUTIONS, INC. as Rights Agent Amended and Restated as of... (Filed With SEC on March 17, 2016)
- PeregrinePharmaceuticals, Inc. Common Stock Purchase Agreement 18,518,518Shares of Common Stock October 30,2015 (Filed With SEC on October 30, 2015)
- PEREGRINE PHARMACEUTICALS, INC. $20,000,000 COMMON STOCK EQUITY DISTRIBUTION AGREEMENT (Filed With SEC on August 7, 2015)
- PeregrinePharmaceuticals, Inc. CommonStock (par value $0.001 per share) At Market Issuance Sales Agreement (Filed With SEC on August 7, 2015)
- PeregrinePharmaceuticals, Inc. Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement (Filed With SEC on June 16, 2014)
- PeregrinePharmaceuticals, Inc. 10.50%Series E Convertible Preferred Stock (liquidationpreference $25.00 per share) At Market Issuance Sales Agreement (Filed With SEC on June 16, 2014)
- PEREGRINEPHARMACEUTICALS, Inc. 700,000 Shares 10.50% Series E Convertible PreferredStock (Plus up an Option to Purchase upto 105,000 Shares to Cover Overallotments) UNDERWRITING... (Filed With SEC on February 12, 2014)
- PeregrinePharmaceuticals, Inc. CommonStock (par value $0.001 per share) At Market Issuance Sales Agreement (Filed With SEC on December 28, 2012)
- WARRANT TO PURCHASE STOCK (Filed With SEC on December 10, 2012)
- WARRANT TO PURCHASE STOCK (Filed With SEC on December 10, 2012)
- WARRANT TO PURCHASE STOCK (Filed With SEC on December 10, 2012)
- CERTAINCONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[**]”. A COMPLETE VERSION OF THIS EXHIBIT HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on December 10, 2012)
- LOANAND SECURITY AGREEMENT (Filed With SEC on July 16, 2012)
- Peregrine Pharmaceuticals, Inc. Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement (Filed With SEC on December 29, 2010)
- ASSIGNMENT AGREEMENT (Filed With SEC on September 9, 2010)
- [Formof Restricted Stock Issuance Agreement dated February 1, 2010] PEREGRINEPHARMACEUTICALS, INC. (Filed With SEC on July 14, 2010)
- WARRANTTO PURCHASE STOCK Company: PEREGRINE PHARMACEUTICALS, INC., a Delaware corporation Number of Shares: 1,184,433, plus all Additional Shares which Holder is entitled to... (Filed With SEC on March 12, 2009)
- WARRANTTO PURCHASE STOCK Company: PEREGRINE PHARMACEUTICALS, INC., a Delaware corporation Number of Shares: 507,614, plus all Additional Shares which Holder is entitled to... (Filed With SEC on March 12, 2009)
- INTELLECTUALPROPERTY SECURITY AGREEMENT (Filed With SEC on March 12, 2009)
- INTELLECTUALPROPERTY SECURITY AGREEMENT (Filed With SEC on March 12, 2009)
- SECUREDTERM PROMISSORY NOTE $3,500,000 December 19, 2008 (Filed With SEC on March 12, 2009)
- SECUREDTERM PROMISSORY NOTE $1,500,000 December 19, 2008 (Filed With SEC on March 12, 2009)
- LOANAND SECURITY AGREEMENT (Filed With SEC on March 12, 2009)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 28, 2007)
- PEREGRINE PHARMACEUTICALS, INC. and INTEGRITY STOCK TRANSFER, INC. as Rights Agent RIGHTS AGREEMENT Dated as of March 16, 2006 TABLE OF CONTENTS (Filed With SEC on March 17, 2006)
